学术探索
学术期刊
新闻热点
数据分析
智能评审

Gemtuzumab ozogamicin: is there room for salvage?

被引：18
作者：
Clarke, W. Thomas [1 ]
Marks, PeterW. [1 ]
机构：
[1] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA
来源：
BLOOD | 2010年 / 116卷 / 14期
关键词：
ACUTE MYELOID-LEUKEMIA; MYLOTARG; THERAPY; TRIAL;
D O I：
10.1182/blood-2010-08-300871
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2618 / 2619
页数：2
相关论文
共 7 条
  • [1] Bross PF, 2001, CLIN CANCER RES, V7, P1490
  • [2] Decitabine combined with fractionated gemtuzumab ozogamicin therapy in patients with relapsed or refractory acute myeloid leukemia
    Chowdhury, Saeeda
    Seropian, Stuart
    Marks, Peter W.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (09) : 599 - 600
  • [3] DILLMAN RO, 1991, BLOOD, V78, P2520
  • [4] Giles Francis J, 2002, Expert Rev Anticancer Ther, V2, P630, DOI 10.1586/14737140.2.6.630
  • [5] Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia
    Lo-Coco, F
    Cimino, G
    Breccia, M
    Noguera, NI
    Diverio, D
    Finolezzi, E
    Pogliani, EM
    Di Bona, E
    Micalizzi, C
    Kropp, M
    Venditti, A
    Tafuri, A
    Mandelli, F
    [J]. BLOOD, 2004, 104 (07) : 1995 - 1999
  • [6] A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group
    Rowe, JM
    Neuberg, D
    Friedenberg, W
    Bennett, JM
    Paietta, E
    Makary, AZ
    Liesveld, JL
    Abboud, CN
    Dewald, G
    Hayes, FA
    Tallman, MS
    Wiernik, PH
    [J]. BLOOD, 2004, 103 (02) : 479 - 485
  • [7] High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group
    Taksin, A-L
    Legrand, O.
    Raffoux, E.
    de Revel, T.
    Thomas, X.
    Contentin, N.
    Bouabdallah, R.
    Pautas, C.
    Turlure, P.
    Reman, O.
    Gardin, C.
    Varet, B.
    de Botton, S.
    Pousset, F.
    Farhat, H.
    Chevret, S.
    Dombret, H.
    Castaigne, S.
    [J]. LEUKEMIA, 2007, 21 (01) : 66 - 71
1